In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...

Hospitals and clinics should plan to spend 11% to 13% more for prescription drugs in 2025 compared to last year, according to new research. For the second consecutive year, Keytruda was the costliest ...

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...